Fig. 3: Comparison of biomarkers early in ICU stay between biomarker-based clusters of critical COVID-19 patients. | Cell Death & Differentiation

Fig. 3: Comparison of biomarkers early in ICU stay between biomarker-based clusters of critical COVID-19 patients.

From: Ferroptosis and pyroptosis signatures in critical COVID-19 patients

Fig. 3

A–I Log2-transformed values of ferroptosis, iron dysregulation, pyroptosis-related interleukins, sRAGE and GDF15 (highest values during first three days after ICU admission) are presented with boxplots (mean, interquartile range and min-max values) in patients from five biomarker-based clusters (1, 2, 3, 4, 5). Pairwise comparisons of values of biomarkers were performed using the Wilcoxon-rank sum test.

Back to article page